Issued Patents 2022
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11530214 | Bicyclic heterocycles as FGFR inhibitors | Liang Lu, Wenqing Yao, Chunhong He | 2022-12-20 |
| 11472791 | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors | Joshua Hummel, Jingwei Li, Zhenwu Li, Ding-Quan Qian, Liangxing Wu +8 more | 2022-10-18 |
| 11465981 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Zhiyong Yu, Wenqing Yao | 2022-10-11 |
| 11407749 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Bo Shen, Jingwei Li, Zhenwu Li, Kai Liu +1 more | 2022-08-09 |
| 11401272 | Heterocyclic compounds as LSD1 inhibitors | Chunhong He, Zhenwu Li, Liangxing Wu, Wenqing Yao | 2022-08-02 |
| 11339149 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Jingwei Li, Wenqing Yao, Chao Qi, Ding-Quan Qian | 2022-05-24 |
| 11247992 | Cyclopropylamines as LSD1 inhibitors | Liangxing Wu, Joel R. Courter, Chunhong He, Xiaozhao Wang, Wenqing Yao | 2022-02-15 |
| 11229631 | Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors | Chu-Biao Xue, Yun-Long Li, Hao Feng, Jun Pan, Anlai Wang +3 more | 2022-01-25 |